Loading

PeerCurrent.com|Stay current with the people and research shaping what comes next.

PcPeerCurrent

Your Feed AI Summary Saved Board Expert Discussion This Week in Your Field

Follows Journals Trials Guidelines Markets

Set your cadence Alerts Settings Help

Back to follows

Institution

University Health Network, Toronto

1 development in the corpus

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

For You Latest Breakthroughs Trials1 Reviews Guidelines

Latest

Everything in the corpus, newest first.

AUG 10, 2026 · PHASE 1 TRIAL

Neurobiological Effects of Psilocybin in Treatment Resistant Bipolar Depression

ClinicalTrials.gov

This is an active Phase 1 proof-of-concept study with no results yet reported; it aims to characterize neurobiological mechanisms in a small, uncontrolled cohort rather than establish clinical efficacy.

PreliminaryBipolar Depression NCT06506019 Psilocybin

Reported

Planned enrollment30

PhasePhase 1

Study designOpen-label, single-arm

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support